Jonathan Beach, DO
Emergency Medicine · Plymouth, NHNPI 1053342600
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,968 of the $10,364 with a category attached, or 67.2%. 8 manufacturers reported payments, led by AstraZeneca at 40.4% of the total. Reporting peaked in 2019 at $10,087 and has fallen 99.8% since, to $23 in 2024. Among emergency medicine clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $280.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- Novo Nordisk$3K
- Medtronic$3K
- Dexcom, Inc.$66
- AbbVie$28
- Sanofi-aventis U.S. LLC$19
- plus $36 from 2 others
What the payments were for
- Speaking & faculty fees$6,96867%
- Travel & lodging$2,52424%
- Food & beverage$8738%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $4,183 |
| Novo Nordisk | 13 | $3,462 |
| Medtronic(2 entities) | 10 | $2,569 |
| Dexcom, Inc. | 3 | $66 |
| AbbVie(2 entities) | 2 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| GSK | 1 | $19 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$4,127
- Ozempic$3,262
- Minimed 630G$1,664
- Minimed 670G System$727
How this compares
$10,364 in reported general payments places this provider in the 95th percentile of 251 emergency medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine Hcl | 23 | $619 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $79 |
| Prednisone | 24 | $67 |
| Cyclobenzaprine Hcl | 12 | $42 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Plymouth
- Norman ParadisLebanon$249K
- Sean NeathManchester$94K
- Zachary SoucyLebanon$6K
- Richard LevitanFranklin$4K
- David HellerPortsmouth$1K
- Nicolette MetrusiasLaconia$811
- Nancy FergusonGrantham$548
- Oliver CardinConcord$378
- John HaggartyConcord$374
- da leDerry$363
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.